A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
Active, not recruiting · NCT07233655 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis | Moderate to Severe Active Rheumatoid Arthritis | Active, not recruiting | Phase 2 | 2026-05-01 | NCT07233655 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangdong Hengrui Pharmaceutical Co., Ltd | 31 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People 's Hospital | Beijing | China | 1 |